Twenty-Five Years of Ambulatory Laparoscopic Cholecystectomy

Bueno-Lledó, José; Castro, Pablo Granero; Gavara, Inmaculada Gomez i; Cirión, Jose L. Ibañez; Andújar, Rafael López; Granero, Eduardo García

doi:10.1016/j.cireng.2016.09.001

Cited by 8 publications

(7 citation statements)

References 108 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reported incidence of unplanned overnight admission ranges between 6% and 25% 16,25–27 . The most common reason in this study for failed DOLC was intraoperative factors, such as the presence of hostile pathology, dense adhesions or abnormal cholangiogram.…”

Section: Discussionmentioning

confidence: 70%

“…This is a similar experience to overseas studies 5,14,16 . Experience in the UK has emphasized the importance of protocols outlining choice of anaesthetic agents, analgesics and antiemetics, 26 as well as nurse‐led pre‐emptive analgesia management in recovery 34 . Despite quoted evidence‐based strategies to optimize DOLC rates, there exists provider‐related barriers which are echoed in studies investigating compliance to ERAS protocols 35,36 …”

Section: Discussionmentioning

confidence: 72%

“…Overseas, patient satisfaction with DOLC is greater, with post‐operative quality‐of‐life scores measuring more than 90% 8 . In some patients, anxiety is a significant barrier to early discharge 26 whilst others expect that part of a normal recovery is time spent in hospital. Adequate preoperative management of expectations is essential as well as the level of information given on patient discharge.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Day‐only elective cholecystectomy: early experience and barriers to implementation in Australia

Pham

Chiong

Sinclair

et al. 2020

ANZ Journal of Surgery

View full text Add to dashboard Cite

This study explores the introduction of routine day‐only laparoscopic cholecystectomy to Westmead Hospital, and highlights the barriers to its implementation. Routine day‐only laparoscopic cholecystectomy can be adopted in Australian hospitals without compromise to patient safety. Individual surgeon and anaesthetist preferences remain an obstacle to a standardized protocol in the Australian setting.

show abstract

Section: Discussionmentioning

confidence: 70%

Section: Discussionmentioning

confidence: 72%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Day‐only elective cholecystectomy: early experience and barriers to implementation in Australia

Pham

Chiong

Sinclair

et al. 2020

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Therefore, establishing principles for optimizing ambulatory procedures is essential for success and patient safety. Although the safety and feasibility of ambulatory LC have been reported for low-risk and high-risk patients 11 – 15 , there is a lack of studies specifically focusing on high-risk patients. Ambulatory LC remains uncommon for patients classified as American Society of Anesthesiologists (ASA) grade III.…”

Section: Introductionmentioning

confidence: 99%

Propensity score-matched comparison of safety outcomes between high-risk and low-risk patients towards early hospital discharge after laparoscopic cholecystectomy

Cheewatanakornkul,

Yolsuriyanwong,

Wangkulangkul

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Background: Laparoscopic cholecystectomy (LC), a common treatment for symptomatic gallstones, has demonstrated safety in low-risk patients. However, existing data is scarce regarding the safety of LC in high-risk patients and the feasibility of early hospital discharge. Materials and Methods: This retrospective study included 2296 patients diagnosed with symptomatic gallstones who underwent LC at a tertiary care center from January 2009 through December 2019. We employed propensity score matching to mitigate bias between groups. Statistical significance was set at P<0.05. Results: The median age of the patients was 56 years (range 46–67), with a mean Body Mass Index (BMI) of 25.2±4.3 kg/m2. Patients were classified as: American Society of Anesthesiologists (ASA) I (19.7%), II (68.3%), III (12.0%), and IV (0%). ASA I–II included low surgical risk patients (88%) and ASA III-IV comprised high-risk patients (12%). The LC-related 30-day reoperative rate was 0.2% and the readmission rate was 0.87%. Nine patients (0.4%) sustained major bile duct injuries, resulting in a conversion rate of 2.4%. The postoperative mortality rate was 0.04%, and the mean hospitalization time was 3.5 days. Patients in the high-risk group with a history of acute cholecystitis exhibited greater estimated blood loss, longer operative times, and were significantly more likely to be in the longer-stay group. Conclusion: Our findings suggest that LC can be conducted safely on high-risk patients, and early hospital discharge is achievable. However, specific factors, such as a history of acute cholecystitis, may result in prolonged hospitalization owing to increased blood loss and longer operative times.

show abstract

“…Laparoscopic cholecystectomy has become the gold standard treatment for symptomatic gallstones and the most common operation performed laparoscopically [1,2,3]. The pain after laparoscopic cholecystectomy frequently occurs due to the stretching of parietal peritoneum, release of inflammatory mediators, and irritation produced by blood [4,5,6].…”

Section: Introductionmentioning

confidence: 99%

The Analgesic Efficacy of Intraperitoneal Ropivacaine Versus Bupivacaine for Laparoscopic Cholecystectomy: a Meta-Analysis

Dong

et al. 2022

Zentralbl Chir

View full text Add to dashboard Cite

Introduction This meta-analysis aimed to compare the analgesic efficacy of intraperitoneal ropivacaine versus bupivacaine for laparoscopic cholecystectomy. Methods We searched PubMed, EMbase, Web of Science, EBSCO, and Cochrane Library databases from inception through January 2020 and included randomized controlled trials (RCTs) evaluating the analgesic efficacy of ropivacaine versus bupivacaine for laparoscopic cholecystectomy. Results Five RCTs are included in the meta-analysis. In patients with laparoscopic cholecystectomy, ropivacaine and bupivacaine demonstrated comparable pain scores at 2 h (SMD = –0.22; 95% CI = –0.54 to 0.10; p = 0.18), 4 h (SMD = –0.16; 95% CI = –0.42 to 0.10; p = 0.22), 8 h (SMD = –0.60; 95% CI = –1.19 to –0.01; p = 0.05), and 24 h (SMD = 0.33; 95% CI = –1.19 to 1.84; p = 0.67), as well as time to first analgesic requirement (SMD = 0.10; 95% CI = –0.23 to 0.42; p = 0.56). Conclusions Intraperitoneal ropivacaine and bupivacaine have a similar analgesic efficacy for laparoscopic cholecystectomy.

show abstract

Twenty-Five Years of Ambulatory Laparoscopic Cholecystectomy

Cited by 8 publications

References 108 publications

Day‐only elective cholecystectomy: early experience and barriers to implementation in Australia

Day‐only elective cholecystectomy: early experience and barriers to implementation in Australia

Propensity score-matched comparison of safety outcomes between high-risk and low-risk patients towards early hospital discharge after laparoscopic cholecystectomy

The Analgesic Efficacy of Intraperitoneal Ropivacaine Versus Bupivacaine for Laparoscopic Cholecystectomy: a Meta-Analysis

Contact Info

Product

Resources

About